Date: 2017-03-02
Type of information: Opening of new premises
Compound: biopharmaceutical production plant
Company: Allergopharma (Germany) Merck KGaA (Germany)
Therapeutic area:
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On March 2, 2017, Merck KGaA announced that its allergy business Allergopharma opened its new biopharmaceutical production in Reinbek, near Hamburg. This new factory covers 6,000 square meters. The entirely glass cleanroom, in which the company will manufacture its products for causal treatment, can be found on the 2,000 square meter ground floor of the building. Merck KGaA, laid the foundations for the building in December 2013. Alongside the cleanrooms for biopharmaceutical production, the new building has ultra-modern technological operations, a glass visitors’ foyer with a view of the cleanrooms and the potential for extension to accommodate further filling lines.
The product range encompasses a diverse spectrum of approved allergen preparations, which correspond to the highest quality standards. AIT (Hyposensitization, desensitization, allergy vaccination) is the only causal therapy option to treat allergies against unavoidable allergens. Almost 500 employees work at the site in Reinbek.
Financial terms:
Latest news:
Is general: Yes
